Moreover, mutations and elevated expression levels of FAM111B have been linked to various fibrotic conditions and malignancies, such as pulmonary fibrosis, thyroid cancer, and lung adenocarcinoma [13–17]. Here, FAM111B is linked to lung adenocarcinoma.